The ACYP2 Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population generated by targeted gene disruption of the ACYP2 locus in Jurkat cells. This product provides a loss-of-function model to investigate the role of acylphosphatase-2 (ACYP2) in T lymphocyte biology. The polyclonal nature ensures representation of diverse editing events, enabling population-level functional studies without clonal selection bias.
The Jurkat cell line is an immortalized T lymphocyte line derived from a human acute T-cell leukemia. These suspension-adapted cells express CD4 surface markers and are extensively used as a model system for T-cell receptor (TCR) signaling, apoptosis, and leukemia research. Jurkat cells retain key signaling machinery of T-cells, making them a robust platform for studying ion-dependent activation mechanisms.
ACYP2 encodes an acylphosphatase that catalyzes the hydrolysis of the carboxyl-phosphate bond in acylphosphates, specifically recognizing the aspartyl-phosphate intermediate of ion pumps such as Na+/K+-ATPase and Ca2+-ATPase. By dephosphorylating these phosphoenzyme intermediates, ACYP2 modulates pump activity and influences intracellular cation homeostasis. In T-cells, ACYP2-mediated regulation of Na+/K+-ATPase and Ca2+-ATPase impacts sodium, potassium, and calcium gradients, thereby affecting downstream calcium-dependent signaling cascades. Cellular cation levels and metabolic state are thought to regulate ACYP2 activity, though upstream regulators remain poorly defined.
In the context of Jurkat T leukemia cells, ACYP2 disruption is predicted to alter cation flux dynamics, particularly calcium mobilization following TCR engagement. Given the central role of calcium oscillations in T-cell activation, cytokine production, and apoptosis, ACYP2 knockout cells provide a unique tool to dissect how ion pump regulation interfaces with immune signal transduction. While ACYP2 genetic variation has been linked to muscle enzyme activity, its precise role in T-cell malignancies is underexplored, underscoring the value of this model for uncovering novel regulatory mechanisms.
Researchers can employ these polyclonal knockout cells in a wide range of functional assays. Calcium flux analyses using Fluo-4 AM indicator dye and flow cytometry directly assess intracellular calcium dynamics upon TCR stimulation. Western blotting for phosphorylated LAT (Y191) and ERK (T202/Y204) evaluates downstream TCR signaling strength. RT-qPCR for IL-2 and IFN-?? monitors transcriptional effects on cytokine expression, while Annexin V staining quantifies apoptosis susceptibility. These cells are also suitable for studies on ion pump pharmacology and cancer cell signaling. For additional technical details, please contact Ascent Research.
